Second COVID reminder becomes OK for some, despite limited evidence it needs

The Food and Drug Administration on Tuesday approved a second COVID-19 booster dose for people 50 and older.

The decision applies to Pfizer and Moderna vaccines. However, with COVID-19 cases still relatively low in the United States, there is “limited evidence” to indicate how much another booster would help, as data from the Centers for Disease Control and Prevention (CDC) indicates that two doses and a booster still provide strong protection against serious infection and death, the Associated Press reported.

This is a developing story and will be updated as more information becomes available.

The FDA has approved another COVID-19 reminder for those 50 and older. Above, a health worker prepares the Pfizer COVID-19 vaccine on March 22 in San Salvador, El Salvador.
Photo by Emerson Flores/APHOTOGRAFIA/Getty Images


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button